Wills Courtney Nelson 4

What Happened
Wills Courtney Nelson, Senior Vice President and General Counsel of MiniMed Group, Inc. (MMED), was granted a total of 55,063 restricted stock units (RSUs) on March 11, 2026. These RSUs resulted from the conversion of previously held Medtronic restricted stock units and performance share units in connection with MMED’s March 9, 2026 separation from Medtronic. No per-share price is reported (transaction code A = award/grant); these are time-vesting equity awards rather than open-market purchases or sales.

Key Details

• Transaction date reported: March 11, 2026; Form 4 filed March 13, 2026 (timely within the 2-business-day requirement).
• Total RSUs granted: 55,063 (individual awards listed: 18,082; 955; 11,486; 5,151; 13,646; 5,743). Price: N/A (conversion-based awards).
• Vesting: Awards are time-vesting RSUs under MMED’s 2026 Long Term Incentive Plan with vesting dates that vary (examples include April 30, 2027; July 31, 2026; July 29, 2027; April 28, 2028).
• Conversion mechanics: The grants stem from an Equity Award Conversion under the Employee Matters Agreement — conversion amounts were based in part on average closing prices of Medtronic and MMED shares around the separation dates.
• Shares owned after transaction: not specified in the reported data.
• Filing code: A (award/grant). This is a corporate conversion of existing Medtronic awards, not a buy/sell transaction.

Context
These RSUs were converted from legacy Medtronic awards as part of the corporate separation and will convert to shares only as they vest; they are not immediate purchases or sales and therefore do not directly signal buying or selling intent. For retail investors, converted/time-vesting awards are common in spin-offs and separations and primarily reflect compensation and retention arrangements rather than market views by the insider.